1. Call to order
2. Approval of minutes from October 22 and October 23, 2020 (vote required)
3. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):
4. Public comment on new drugs to be reviewed for the Medicaid PDL:
5. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration
6. Executive work session
1. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration (vote required)
2. Retrospective drug utilization review (DUR): Conduent, LLC
3. Prospective prior authorization proposals (clinical edits): KEPRO, LLC (vote required)
4. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy (vote required)
Items 5 & 6